including tests on cell cultures expressing recombinant COX-1 or COX-2 enzymes and whole-blood assays measuring the production of either thromboxane by platelets (an index of COX-1 activity ...

A recent groundbreaking study found that Glucagon-like peptide 1 receptor agonists (GLP1-RA) are effective in reducing venous ...

The currently available antiplatelet drugs target key steps of platelet activation including thromboxane A 2 synthesis, ADP-mediated signaling, and glycoprotein IIb/IIIa-mediated platelet aggregation.